Investing in Exponential Growth Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Investing in Exponential Growth

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Paul H. Christiansen	8/3/2016 2:50:34 PM
	of 1084

Veeva Helps The Medicine Go Down Faster for Drug Giants When health care behemoth Johnson & Johnson ( JNJ) decided last year to use Veeva Systems' ( VEEV) software for gathering data from clinical trials needed to get a new drug approved, Veeva's rivals took notice. For good reason. Thanks to J&J, it wasn't long before Veeva's content management application turned the heads of its potential customers as well. "They (J&J) said we're going to standardize this globally, and within 12 months we had 6 customers (among the 20 biggest drugmakers) do the exact same thing," Veeva Chief Financial Officer Timothy Cabral told a Stifel technology conference in June. In this case, though, imitation wasn't just the sincerest form of flattery; it was pretty much according to plan. The cloud-based software company's insiders call it "the Veeva way." By that, they mean rapidly developing industry-specific applications with functionality that is miles ahead of the legacy offerings. Then they use positive customer outcomes to take the market by storm. investors.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next